Applied Clinical Trials-05-01-2013

Subject Recruitment: The Ideas Initiative Trial Design: Early Phase CNS Drug Liabilities; Improving Enrollment Forecasts Also in this issue: Update on Europe's Clinical Trial Rules Debate Public Perception of Clinical Research Clinical Trial Barriers

Medidata Solutions

Improving diversity, education, and advancement in studies: a look at the IDEAS initiative.

The Avoca Group's "2012 Industry Survey," sponsors and service providers were asked to share their experiences with strategic partnerships.

Oncology clinical trials: A case for Russia and Eastern Europe.

Tufts CSDD

Medidata Solutions

A useful tool for clinical research professionals to estimate potential recruitment duration.

The statistics show that fewer and fewer physicians are willing to take part in trials and that around half of those that do so once never do so again.

S

Only eight percent of CNS drugs will reach approval, in part because of the high adverse effects standards.

S

Industry news focusing on the people and organizations who work in the clinical trials profession.

Debate rages on, European Parliament set to decide on new clinical trial rules in late October.

Accelerating the discovery and delivery of personalized medicine.

Public's view of clinical research has improved during the past five years, CISCRP survey reveals.

There is great optimism that new genomic discoveries and technical advances will reduce the cost and time of moving important new therapies for cancer and other critical diseases from laboratory to patients.

Workers from France, Italy, and Spain account for more than a third of total staff at the European Medicines Agency, plus around 68% of agency staff members are women, according to new statistics.

Increasing development costs and high failure rates require earlier integration of imaging data in the Phase I setting.